Aniket Bankar, MD, discusses why rusfertide is considered a promising therapeutic approach for patients with polycythemia vera.
Aniket Bankar, MD
Aniket Bankar, MBBS, MD, DM, MSc Clin Epi (c) is a hematologist and health services researcher at Princess Margaret Cancer Center in Toronto, Canada